Rafael Galindo, MD, PhD

Rafael Galindo, MD, PhD, is a pediatric neurologist with a specialized clinical and research interest in neonatal neurology. His clinical focus primarily involves the evaluation of newborns and infants with a history of neonatal and/or perinatal brain injury. He also evaluates and treat progressive neurological disorders with a special interest in newborn and childhood-onset leukodystrophies including Krabbe disease and X-linked adrenoleukodystrophy.

Galindo’s neuroscientific research involves exploring novel neuroprotective strategies and understanding neurobiological mechanisms that regulate neuronal survival and death in the injured neonatal brain. Specifically, he is examining the role and associated cellular mechanisms of Nicotinamide Mononucleotide Adenylyltransferases (NMNATs), sterile alpha- and armadillo-motif-containing protein (SARM) and human Chorionic Gonadotropin (hCG) in maintaining neuronal survival of injured developing neurons and brain. In addition, another part of my research effort is aimed at developing new function-based animal models for the systematic evaluation of the neurological comorbidities associated with neonatal cerebral injury. To this end, he is developing new technologies and methods for evaluating cortical network connectivity and seizures during and/or following neonatal HI.